| 1 |
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection |
|
|
| Greta Volpedo, Ryan H Huston, Erin A Holcomb, Thalia Pacheco-Fernandez, Sreenivas Gannavaram, Parna Bhattacharya, Hira L Nakhasi, Abhay R Satoskar |
|
| Expert Review of Vaccines. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Efficacy and Safety of Paromomycin for Visceral Leishmaniasis: A Systematic Review |
|
|
| Pashupati Pokharel, Rakesh Ghimire, Pratik Lamichhane, Alemayehu Toma |
|
| Journal of Tropical Medicine. 2021; 2021: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
STRUCTURAL FEATURE STUDY OF FUROXAN DERIVATIVES AS POTENT ANTI-TRYPANOSOMATID AGENTS: QSAR APPROACH |
|
|
| M. C. Sharma |
|
| INDIAN DRUGS. 2016; 53(09): 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Gibbilimbol analogues as antiparasitic agents—Synthesis and biological activity against Trypanosoma cruzi and Leishmania (L.) infantum |
|
|
| Marina T. Varela,Roberto Z. Dias,Ligia F. Martins,Daiane D. Ferreira,Andre G. Tempone,Anderson K. Ueno,João Henrique G. Lago,João Paulo S. Fernandes |
|
| Bioorganic & Medicinal Chemistry Letters. 2016; 26(4): 1180 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Evaluation of the leishmanicidal and cytotoxic effects of inhibitors for microorganism metabolic pathway enzymes |
|
|
| Ademar de Mesquita Barbosa,Solange dos Santos Costa,Josmar Rodrigues da Rocha,Carlos Alberto Montanari,Selma Giorgio |
|
| Biomedicine & Pharmacotherapy. 2015; 74: 95 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L. |
|
|
| Camilla R. Dal Picolo,Mariana P. Bezerra,Kaio S. Gomes,Luiz Felipe D. Passero,Marcia D. Laurenti,Euder Glendes A. Martins,Patricia Sartorelli,João Henrique G. Lago |
|
| Fitoterapia. 2014; 97: 28 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies |
|
|
| Muzamil Yaqub Want,Mohammad Islamuddin,Garima Chouhan,Anjan Kumar Dasgupta,Asoke Prasun Chattopadhyay,Farhat Afrin |
|
| Journal of Colloid and Interface Science. 2014; 432: 258 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences |
|
|
| Katerina Juzlova,Jana Votrubova,Denisa Kacerovska,Milan Lukas,Martin Bortlik,Hana Rohacova,Eva Nohynkova,Nadezda Vojackova,Jorga Fialova,Jana Hercogova |
|
| Dermatologic Therapy. 2013; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
In Vitro and In Vivo Studies of Antileishmanial Effect of Artemether on Leishmania infantum |
|
|
| Nahid Mortazavi Dehkordi,Fatemeh Ghaffarifar,Zuhair Mohammad Hassan,Farzad Esavand Heydari |
|
| Jundishapur Journal of Microbiology. 2013; 6(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis |
|
|
| Tejinder Kaur, Prerna Makkar, Kulbir Randhawa, Sukhbir Kaur |
|
| Parasitology Research. 2013; 112(1): 91 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 11 |
Visceral Leishmaniasis Clinical Management in Endemic Districts of India, Nepal, and Bangladesh |
|
|
| Megha Raj Banjara,Siddhivinayak Hirve,Niyamat Ali Siddiqui,Narendra Kumar,Sangeeta Kansal,M. Mamun Huda,Pradeep Das,Suman Rijal,Chitra Kumar Gurung,Paritosh Malaviya,Byron Arana,Axel Kroeger,Dinesh Mondal |
|
| Journal of Tropical Medicine. 2012; 2012: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Protective Therapy with Novel Chromone Derivative against Leishmania donovani Infection Induces Th1 Response in vivo |
|
|
| Suvadip Mallick,Aritri Dutta,Joydip Ghosh,Sourav Maiti,Ajay Kumar Mandal,Rajat Banerjee,Chandrakanta Bandyopadhyay,Chiranjib Pal |
|
| Chemotherapy. 2011; 57(5): 388 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
3-Trifluoromethylquinoxaline <i>N</i>,<i>N</i>′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-<i>T. cruzi</i> Agents and Mechanism of Action Studies |
|
|
| |
|
| Journal of Medicinal Chemistry. 2011; 54(10): 3624 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 14 |
Traitement des leishmanioses en France : proposition d’un référentiel consensuel |
|
|
| Pierre A. Buffet,Éric Rosenthal,Jean-Pierre Gangneux,Edward Lightburne,Pierre Couppié,Gloria Morizot,Laurence Lachaud,Pierre Marty,Jean-Pierre Dedet |
|
| La Presse Médicale. 2011; 40(2): 173 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Importance of Nonenteric Protozoan Infections in Immunocompromised People |
|
|
| J. L. N. Barratt, J. Harkness, D. Marriott, J. T. Ellis, D. Stark |
|
| Clinical Microbiology Reviews. 2010; 23(4): 795 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Drug delivery strategies for therapy of visceral leishmaniasis |
|
|
| Swati Gupta,Ajay Pal,Suresh P Vyas |
|
| Expert Opinion on Drug Delivery. 2010; 7(3): 371 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Drug delivery strategies for therapy of visceral leishmaniasis |
|
|
| Gupta, S., Pal, A., Vyas, S.P. |
|
| Expert Opinion on Drug Delivery. 2010; 7(3): 371-402 |
|
| [Pubmed] [Google Scholar] |
|
| 18 |
Liposomal amphotericin B as treatment for visceral leishmaniasis in Europe, 2009 | [Le traitement de la leishmaniose viscérale en Europe en 2009. Place de læamphotéricine B liposomale] |
|
|
| Rosenthal, E., Delaunay, P., Jeandel, P.-Y., Haas, H., Pomares-Estran, C., Marty, P. |
|
| Medecine et Maladies Infectieuses. 2009; 39(10): 741-744 |
|
| [Pubmed] [Google Scholar] |
|
| 19 |
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India |
|
|
| Das, V.N.R., Siddiqui, N.A., Pandey, K., Singh, V.P., Topno, R.K., Singh, D., Verma, R.B.,Das, P. |
|
| Therapeutics and Clinical Risk Management. 2009; 5(1): 117-124 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: Synthesis, biological evaluation, and mode of action studies |
|
|
| Boiani, M., Boiani, L., Merlino, A., Hernández, P., Chidichimo, A., Cazzulo, J.J., Cerecetto, H., González, M. |
|
| European Journal of Medicinal Chemistry. 2009; 44(11): 4426-4433 |
|
| [Pubmed] [Google Scholar] |
|
| 21 |
Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents |
|
|
| Boutaleb-Charki, S., Marín, C., Maldonado, C.R., Rosales, M.J., Urbano, J., Guitierrez-Sánchez, R., Quirós, M.,Sánchez-Moreno, M. |
|
| Drug Metabolism Letters. 2009; 3(1): 35-44 |
|
| [Pubmed] [Google Scholar] |
|
| 22 |
Le traitement de la leishmaniose viscérale en Europe en 2009. Place de l’amphotéricine B liposomale |
|
|
| E. Rosenthal,P. Delaunay,P.-Y. Jeandel,H. Haas,C. Pomares-Estran,P. Marty |
|
| Médecine et Maladies Infectieuses. 2009; 39(10): 741 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Anti-trypanosomatid benzofuroxans and deoxygenated analogues: Synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies |
|
|
| Diego Castro, Lucia Boiani, Diego Benitez, Paola Hernández, Alicia Merlino, Carmen Gil, Claudio Olea-Azar, Mercedes González, Hugo Cerecetto, Williams Porcal |
|
| European Journal of Medicinal Chemistry. 2009; 44(12): 5055 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 24 |
Masa orofaríngea en paciente con infección por VIH |
|
|
| Luis Mérida Rodrigo, Julián Olalla Sierra, Alfonso del Arco Jiménez, Isabel Rodrigo Fernández |
|
| Acta Otorrinolaringológica Española. 2008; 59(4): 202 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 25 |
Oro-Pharyngeal Mass in a Patient With HIV Infection |
|
|
| Luis Mérida Rodrigo, Julián Olalla Sierra, Alfonso del Arco Jiménez, Isabel Rodrigo Fernández |
|
| Acta Otorrinolaringologica (English Edition). 2008; 59(4): 202 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 26 |
Targeting glycoproteins or glycolipids and their metabolic pathways for antiparasite therapy |
|
|
| Mandal, C., Nee Bandyopadhyay, S.M. |
|
| Advances in Experimental Medicine and Biology. 2008; 625: 87-102 |
|
| [Pubmed] [Google Scholar] |
|
| 27 |
Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies |
|
|
| Boiani, L., Aguirre, G., González, M., Cerecetto, H., Chidichimo, A., Cazzulo, J.J., Bertinaria, M., Guglielmo, S. |
|
| Bioorganic and Medicinal Chemistry. 2008; 16(17): 7900-7907 |
|
| [Pubmed] [Google Scholar] |
|
| 28 |
Leishmaniasis: Drug resistance and natural products (review) |
|
|
| Polonio, T., Efferth, T. |
|
| International Journal of Molecular Medicine. 2008; 22(3): 277-286 |
|
| [Pubmed] [Google Scholar] |
|
| 29 |
Oro-pharyngeal mass in a patient with HIV infection | [Masa orofaríngea en paciente con infección por VIH] |
|
|
| Mérida Rodrigo, L., Sierra, J.O., Jiménez, A.D.A., Fernández, I.R. |
|
| Acta Otorrinolaringologica Espanola. 2008; 59(4): 202-203 |
|
| [Pubmed] [Google Scholar] |
|
| 30 |
Mitochondrion of protozoan parasite emerges as potent therapeutic target: Exciting drugs are on the horizon |
|
|
| Sen, N., Majumder, H.K. |
|
| Current Pharmaceutical Design. 2008; 14(9): 839-846 |
|
| [Pubmed] [Google Scholar] |
|
| 31 |
Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies |
|
|
| Luci´a Boiani,Gabriela Aguirre,Mercedes González,Hugo Cerecetto,Agustina Chidichimo,Juan J. Cazzulo,Massimo Bertinaria,Stefano Guglielmo |
|
| Bioorganic & Medicinal Chemistry. 2008; 16(17): 7900 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: The significance of amphotericin B in the control of Leishmania donovani infection in India |
|
|
| Saha S, Mondal S, Ravindran R, et al. |
|
| JOURNAL OF IMMUNOLOGY. 2007; 179 (8): 5592-5603 |
|
| [Pubmed] [Google Scholar] |
|
| 33 |
Injectable paromomycin for visceral leishmaniasis in India |
|
|
| Sundar, S., Jha, T.K., Thakur, C.P., Sinha, P.K., Bhattacharya, S.K. |
|
| New England Journal of Medicine. 2007; 356(25): 2571-2581 |
|
| [Pubmed] [Google Scholar] |
|
| 34 |
Leishmaniasis (Reprinted from vol 82, pg 649-657, 2006) |
|
|
| Piscopo TV, Azzopardi CM |
|
| POSTGRADUATE MEDICAL JOURNAL. 2007; 83 (976): 649-657 |
|
| [Pubmed] [Google Scholar] |
|
| 35 |
Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors |
|
|
| Granthon AC, Braga MV, Rodrigues JCF, et al. |
|
| VETERINARY PARASITOLOGY. 2007; 146 (1-2): 25-34 |
|
| [Pubmed] [Google Scholar] |
|
| 36 |
Injectable Paromomycin for Visceral Leishmaniasis in India |
|
|
| Shyam Sundar,T.K. Jha,Chandreshwar P. Thakur,Prabhat K. Sinha,Sujit K. Bhattacharya |
|
| New England Journal of Medicine. 2007; 356(25): 2571 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors |
|
|
| Ana Claudia Granthon,Marina V. Braga,Juliany C.F. Rodrigues,Simon Cammerer,Silvia Orenes Lorente,Ian H. Gilbert,Julio A. Urbina,Wanderley de Souza |
|
| Veterinary Parasitology. 2007; 146(1-2): 25 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
IL-10- and TGF-ß-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India |
|
|
| Samiran Saha, Smriti Mondal, Rajesh Ravindran, Swati Bhowmick, Dolanchampa Modak, Sudeshna Mallick, Mehboobar Rahman, Sourjya Kar, Ramaprasad Goswami, Subhasis Kamal Guha, Netai Pramanik, Bibhuti Saha, Nahid Ali |
|
| The Journal of Immunology. 2007; 179(8): 5592 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Leishmaniasis |
|
|
| Tonio V Piscopo, Charles Mallia Azzopardi |
|
| Postgraduate Medical Journal. 2007; 83(976): 649 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
An intracellular calcium store is present in Leishmania donovani glycosomes |
|
|
| Shreedhara Gupta,Bikramjit Raychaudhury,Shouvik Banerjee,Banasri Das,Salil C. Datta |
|
| Experimental Parasitology. 2006; 113(3): 161 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
2H-Benzimidazole 1,3-Dioxide Derivatives:? A New Family of Water-Soluble Anti-Trypanosomatid Agents |
|
|
| Mariana Boiani, Lucía Boiani, Ana Denicola, Susana Torres de Ortiz, Elva Serna, Ninfa Vera de Bilbao, Luis Sanabria, Gloria Yaluff, Héctor Nakayama, Antonieta Rojas de Arias, Celeste Vega, Miriam Rolan, Alicia Gómez-Barrio, Hugo Cerecetto, Mercedes González |
|
| Journal of Medicinal Chemistry. 2006; 49(11): 3215 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Leishmaniasis |
|
|
| T V Piscopo, A C Mallia |
|
| Postgraduate Medical Journal. 2006; 82(972): 649 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
An intracellular calcium store is present in Leishmania donovani glycosomes |
|
|
| Gupta S, Raychaudhury B, Banerjee S, et al. |
|
| EXPERIMENTAL PARASITOLOGY. 2006; 113 (3): 161-167 |
|
| [Pubmed] [Google Scholar] |
|
| 44 |
2H-benzimidazole 1,3-dioxide derivatives: A new family of water-soluble anti-trypanosomatid agents |
|
|
| Boiani M, Boiani L, Denicola A, et al. |
|
| JOURNAL OF MEDICINAL CHEMISTRY. 2006; 49 (11): 3215-3224 |
|
| [Pubmed] [Google Scholar] |
|
| 45 |
Leishmaniasis |
|
|
| Piscopo TV, Mallia AC |
|
| POSTGRADUATE MEDICAL JOURNAL. 2006; 82 (972): 649-657 |
|
| [Pubmed] [Google Scholar] |
|
| 46 |
Interferon gamma unresponsiveness due to down-regulation of IFN-R expression in experimental cutaneous leishmaniasis |
|
|
| Kariminia, A., Ardestani, S.K., Ardestani, N.A.-S., Sepehry, H., Darabi, H. |
|
| Iranian Biomedical Journal. 2006; 10(2): 105-109 |
|
| [Pubmed] [Google Scholar] |
|
| 47 |
Leishmania/HIV co-infections in the second decade |
|
|
| Cruz, I., Nieto, J., Moreno, J., Cañavate, C., Desjeux, P., Alvar, J. |
|
| Indian Journal of Medical Research. 2006; 123(3): 357-388 |
|
| [Pubmed] [Google Scholar] |
|
| 48 |
Apoptosis in Leishmania species & its relevance to disease pathogenesis |
|
|
| Shaha, C. |
|
| Indian Journal of Medical Research. 2006; 123(3): 233-244 |
|
| [Pubmed] [Google Scholar] |
|
| 49 |
Syntheses of new substituted triazino tetrahydroisoquinolines and β-carbolines as novel antileishmanial agents |
|
|
| Kumar, A., Katiyar, S.B., Gupta, S., Chauhan, P.M.S. |
|
| European Journal of Medicinal Chemistry. 2006; 41(1): 106-113 |
|
| [Pubmed] [Google Scholar] |
|
| 50 |
Synthesis and in vitro antileishmanial activity of 5-substituted-2′- deoxyuridine derivatives |
|
|
| Peyron, C., Benhida, R., Bories, C., Loiseau, P.M. |
|
| Bioorganic Chemistry. 2005; 33(6): 439-447 |
|
| [Pubmed] [Google Scholar] |
|
| 51 |
Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network |
|
|
| Weitzel T, Muhlberger N, Jelinek T, et al. |
|
| EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2005; 24 (7): 471-476 |
|
| [Pubmed] [Google Scholar] |
|
| 52 |
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region |
|
|
| F. Pasquau,J. Ena,R. Sanchez,J. M. Cuadrado,C. Amador,J. Flores,C. Benito,C. Redondo,J. Lacruz,V. Abril,J. Onofre |
|
| European Journal of Clinical Microbiology & Infectious Diseases. 2005; 24(6): 411 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 53 |
Imported leishmaniasis in Germany 2001–2004: data of the SIMPID surveillance network |
|
|
| T. Weitzel,N. Mühlberger,T. Jelinek,M. Schunk,S. Ehrhardt,C. Bogdan,K. Arasteh,T. Schneider,W. V. Kern,G. Fätkenheuer,G. Boecken,T. Zoller,M. Probst,M. Peters,T. Weinke,S. Gfrörer,H. Klinker,M.-L. Holthoff-Stich |
|
| European Journal of Clinical Microbiology & Infectious Diseases. 2005; 24(7): 471 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 54 |
Leishmania-host interplay: The everlasting rivalry |
|
|
| Martiny, A., Vannier-Santos, M.A. |
|
| Medicinal Chemistry Reviews - Online. 2005; 2(3): 231-249 |
|
| [Pubmed] [Google Scholar] |
|
| 55 |
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region |
|
|
| Pasquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, Flores J, Benito C, Redondo C, Lacruz J, Abril V, Onofre J |
|
| EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2005; 24 (6): 411-418 |
|
| [Pubmed] [Google Scholar] |
|
| 56 |
Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives |
|
|
| Corinne Peyron,Rachid Benhida,Christian Bories,Philippe M. Loiseau |
|
| Bioorganic Chemistry. 2005; 33(6): 439 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 57 |
In vitro assays for evaluation of drug activity against Leishmania spp. |
|
|
| Luciana Fumarola,Rosa Spinelli,Olga Brandonisio |
|
| Research in Microbiology. 2004; 155(4): 224 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 58 |
Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection |
|
|
| H. Sindermann,K. R. Engel,C. Fischer,W. Bommer |
|
| Clinical Infectious Diseases. 2004; 39(10): 1520 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 59 |
Challenges and new discoveries in the treatment of leishmaniasis |
|
|
| Singh, S., Sivakumar, R. |
|
| Journal of Infection and Chemotherapy. 2004; 10(6): 307-315 |
|
| [Pubmed] [Google Scholar] |
|
| 60 |
Visceral leishmaniases |
|
|
| Rosenthal, É., Marty, P. |
|
| Revue du Praticien. 2004; 54(20): 2211-2216 |
|
| [Pubmed] [Google Scholar] |
|
| 61 |
Isolation of Leishmania glycosomes by a rapid method |
|
|
| Raychaudhury B, Gupta S, Banerjee S, et al. |
|
| ANALYTICAL BIOCHEMISTRY. 2004; 332 (2): 404-408 |
|
| [Pubmed] [Google Scholar] |
|
| 62 |
Visceral leishmaniasis: A trip to the Greek Islands is not always idyllic |
|
|
| Ju, O., Grove, D.I., Jaksic, W.J., Dart, G.W. |
|
| Medical Journal of Australia. 2004; 181(8): 446-447 |
|
| [Pubmed] [Google Scholar] |
|
| 63 |
Challenges and new discoveries in the treatment of leishmaniasis |
|
|
| Sarman Singh,Ramu Sivakumar |
|
| Journal of Infection and Chemotherapy. 2004; 10(6): 307 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 64 |
Isolation of Leishmania glycosomes by a rapid method |
|
|
| Bikramjit Raychaudhury,Shreedhara Gupta,Shouvik Banerjee,Banasri Das,Salil C. Datta |
|
| Analytical Biochemistry. 2004; 332(2): 404 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 65 |
In vitro assays for evaluation of drug activity against Leishmania spp. |
|
|
| Fumarola L, Spinelli R, Brandonisio O |
|
| Research in Microbiology. 2004; 155 (4): 224-230 |
|
| [Pubmed] [Google Scholar] |
|
| 66 |
Oral miltefosine for leishmaniasis in immunocompromised patients: Compassionate use in 39 patients with HIV infection |
|
|
| Sindermann, H., Engel, K.R., Fischer, C., Bommer, W. |
|
| Clinical Infectious Diseases. 2004; 39(10): 1520-1523 |
|
| [Pubmed] [Google Scholar] |
|
| 67 |
Leishmania - From the bite to the disease |
|
|
| Cebalo, L. |
|
| Infektoloski Glasnik. 2003; 23(4): 197-204 |
|
| [Pubmed] [Google Scholar] |
|
